Results 241 to 250 of about 74,934 (299)

Toll-like receptor 9 (TLR9) [PDF]

Science-Business eXchange, 2010
openaire   +1 more source

BDCA2 plays a central role in the binding, internalization and response of plasmacytoid dendritic cells to vidutolimod. [PDF]

Front Immunol
Lemke-Miltner CD, Blackwell SE, Yin C, Fischer TD, Weiner GJ.   +4 more
europepmc   +1 more source

Miniature rose alleviates inflammatory bowel disease in mice by modulating gut microbiota, inhibiting TLR4, enhancing tight junction proteins, and promoting metabolism. [PDF]

Front Microbiol
Wu J, Mao X.
europepmc   +1 more source

Advances in Elucidating the Mitochondrial DNA Mechanisms Underlying Ozone-Induced Inflammation. [PDF]

Toxics
Chen Q, Liu H, Zhou J, Wei Y, He L.
europepmc   +1 more source

STAT1 drives the immune landscape of murine Toll-like receptor 9-induced liver inflammation. [PDF]

JHEP Rep
De Visscher A, Beliën J, Bernaerts E, Vandeput M, Malengier-Devlies B, Prenen F, Meers H, Sokol L, Mitera T, Berghmans N, Anak S, Govaere O, Van den Steen P, Lamote J, Vandamme N, Bujko A, Scott CL, Wouters CH, Matthys P.   +18 more
europepmc   +1 more source

Reduced TLR3 and TLR9 Expression in Epidermodysplasia Verruciformis: Evidence From a Comparative Skin Study. [PDF]

J Med Virol
Fróes LAR, Pereira CCDA, Silva LLDC, Pereira NV, de Oliveira WRP, Sotto MN.   +5 more
europepmc   +1 more source

TLR4 rs4986790 and TLR9 rs5743836 Polymorphisms and Their Association With Clinical Outcomes of Leishmania infantum Infection in Tunisia. [PDF]

Cureus
Chargui N, Mtiraoui N, Chaabane Banaoues R, Babba H, Sakly W.   +4 more
europepmc   +1 more source

Pre-activation timing determines influenza severity and viral pathogenicity via STING Inhibition. [PDF]

Sci Rep
Zhu T, Zhu M, Lu F, Qu K, Wang H, Wang S, Sun Z, Yu Y, Wang L, Yan C.   +9 more
europepmc   +1 more source

Heterozygous variants in DOCK2 leading to susceptibility to viral illnesses. [PDF]

J Allergy Clin Immunol
Al-Musa A, Platt C, Elkins M, Novak T, Woods B, Bourdine A, Magin L, Craiglow BG, Newhams MM, Kong M, Randolph A, Chou J.   +11 more
europepmc   +1 more source

TLR agonists as adjuvants for viral vaccines: mechanisms, applications, and future directions. [PDF]

Front Microbiol
Shao F, Zhu X, Yi M, Gao H, Wu J, Fang R, Xie Y, Han J, Lu H.   +8 more
europepmc   +1 more source